Johnson Pharmacare Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 17.29 million. Revenue was INR 17.29 million. Net income was INR 2.69 million compared to net loss of INR 0.414 million a year ago. Basic earnings per share from continuing operations was INR 0.0045 compared to basic loss per share from continuing operations of INR 0.0009 a year ago. Diluted earnings per share from continuing operations was INR 0.0045 compared to diluted loss per share from continuing operations of INR 0.0009 a year ago.
For the six months, sales was INR 32.63 million. Revenue was INR 32.63 million. Net income was INR 4.87 million compared to net loss of INR 0.474 million a year ago. Basic earnings per share from continuing operations was INR 0.0091 compared to basic loss per share from continuing operations of INR 0.0009 a year ago. Diluted earnings per share from continuing operations was INR 0.0091 compared to diluted loss per share from continuing operations of INR 0.0009 a year ago.